Pharmaceutical

Bumrungrad International Hospital Partners with Golden Helix to Advance Genomics for Cancer and Hereditary Disease Initiatives

BOZEMAN, Mont., Nov. 14, 2024 /PRNewswire/ -- Bumrungrad International Hospital, a leading global healthcare provider based in Bangkok, Thailand, and…

2 months ago

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

LONDON, Nov. 14, 2024 /PRNewswire/ -- Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer. Alexander…

2 months ago

Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science’s Biggest Challenges

RADNOR, Pa., Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to…

2 months ago

Veeva Pulse Data Shows New Science Calls for More Connected Engagement

Synchronizing sales and marketing improves outcomes, yet 65% of field engagements are not PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ --…

2 months ago

Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,…

2 months ago

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria…

2 months ago

NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates

Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury…

2 months ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…

2 months ago

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity

-- Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a…

2 months ago

FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's…

2 months ago